Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment

Patients undergoing complex percutaneous coronary intervention (PCI) are at an increased risk of atherothrombotic complications. Although dual antiplatelet therapy is the mainstay of treatment for patients undergoing PCI with stent implantation, deciding its type and duration in complex PCI patients...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Despoina-Rafailia Benetou, Charalampos Varlamos, Christos Pappas, Fotios Kolokathis, Dimitrios Alexopoulos
Formato:	article
Lenguaje:	EN
Publicado:	Radcliffe Medical Media 2021
Materias:	Diseases of the circulatory (Cardiovascular) system RC666-701
Acceso en línea:	https://doaj.org/article/5b6f64e6a44a4cc9b162c9ac93c3aff0
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:5b6f64e6a44a4cc9b162c9ac93c3aff0
record_format	dspace
spelling	oai:doaj.org-article:5b6f64e6a44a4cc9b162c9ac93c3aff02021-12-04T16:05:05ZAntithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment10.15420/usc.2020.301758-390X1758-3896https://doaj.org/article/5b6f64e6a44a4cc9b162c9ac93c3aff02021-10-01T00:00:00Zhttps://www.uscjournal.com/articleindex/usc.2020.30https://doaj.org/toc/1758-3896https://doaj.org/toc/1758-390XPatients undergoing complex percutaneous coronary intervention (PCI) are at an increased risk of atherothrombotic complications. Although dual antiplatelet therapy is the mainstay of treatment for patients undergoing PCI with stent implantation, deciding its type and duration in complex PCI patients has long been considered a challenge for clinicians. This is because the beneficial effects of prolonged treatment and/or more potent antiplatelet agents’ use in preventing ischemic events are hindered by a concomitant increase in bleeding complications. The aim of this review is to highlight current evidence regarding the optimal antithrombotic therapy regimens used in complex PCI patients, focusing on the evaluation of both safety and efficacy outcomes as well as addressing future perspectives.Despoina-Rafailia BenetouCharalampos VarlamosChristos PappasFotios KolokathisDimitrios AlexopoulosRadcliffe Medical MediaarticleDiseases of the circulatory (Cardiovascular) systemRC666-701ENUS Cardiology Review , Vol 15, Iss , Pp - (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	Diseases of the circulatory (Cardiovascular) system RC666-701
spellingShingle	Diseases of the circulatory (Cardiovascular) system RC666-701 Despoina-Rafailia Benetou Charalampos Varlamos Christos Pappas Fotios Kolokathis Dimitrios Alexopoulos Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
description	Patients undergoing complex percutaneous coronary intervention (PCI) are at an increased risk of atherothrombotic complications. Although dual antiplatelet therapy is the mainstay of treatment for patients undergoing PCI with stent implantation, deciding its type and duration in complex PCI patients has long been considered a challenge for clinicians. This is because the beneficial effects of prolonged treatment and/or more potent antiplatelet agents’ use in preventing ischemic events are hindered by a concomitant increase in bleeding complications. The aim of this review is to highlight current evidence regarding the optimal antithrombotic therapy regimens used in complex PCI patients, focusing on the evaluation of both safety and efficacy outcomes as well as addressing future perspectives.
format	article
author	Despoina-Rafailia Benetou Charalampos Varlamos Christos Pappas Fotios Kolokathis Dimitrios Alexopoulos
author_facet	Despoina-Rafailia Benetou Charalampos Varlamos Christos Pappas Fotios Kolokathis Dimitrios Alexopoulos
author_sort	Despoina-Rafailia Benetou
title	Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
title_short	Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
title_full	Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
title_fullStr	Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
title_full_unstemmed	Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment
title_sort	antithrombotics in complex percutaneous coronary interventions: type and duration of treatment
publisher	Radcliffe Medical Media
publishDate	2021
url	https://doaj.org/article/5b6f64e6a44a4cc9b162c9ac93c3aff0
work_keys_str_mv	AT despoinarafailiabenetou antithromboticsincomplexpercutaneouscoronaryinterventionstypeanddurationoftreatment AT charalamposvarlamos antithromboticsincomplexpercutaneouscoronaryinterventionstypeanddurationoftreatment AT christospappas antithromboticsincomplexpercutaneouscoronaryinterventionstypeanddurationoftreatment AT fotioskolokathis antithromboticsincomplexpercutaneouscoronaryinterventionstypeanddurationoftreatment AT dimitriosalexopoulos antithromboticsincomplexpercutaneouscoronaryinterventionstypeanddurationoftreatment
_version_	1718372675096674304

Antithrombotics in Complex Percutaneous Coronary Interventions: Type and Duration of Treatment

Ejemplares similares